Stella Pharma Statistics
Total Valuation
Stella Pharma has a market cap or net worth of JPY 16.39 billion. The enterprise value is 13.44 billion.
Important Dates
The last earnings date was Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Stella Pharma has 38.03 million shares outstanding. The number of shares has increased by 2.39% in one year.
| Current Share Class | 38.03M |
| Shares Outstanding | 38.03M |
| Shares Change (YoY) | +2.39% |
| Shares Change (QoQ) | +4.03% |
| Owned by Insiders (%) | 3.95% |
| Owned by Institutions (%) | 5.61% |
| Float | 23.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 55.14 |
| PB Ratio | 5.01 |
| P/TBV Ratio | 5.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 45.24 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.53, with a Debt / Equity ratio of 0.26.
| Current Ratio | 15.53 |
| Quick Ratio | 11.24 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -67.64 |
Financial Efficiency
Return on equity (ROE) is -30.50% and return on invested capital (ROIC) is -15.33%.
| Return on Equity (ROE) | -30.50% |
| Return on Assets (ROA) | -11.34% |
| Return on Invested Capital (ROIC) | -15.33% |
| Return on Capital Employed (ROCE) | -18.31% |
| Weighted Average Cost of Capital (WACC) | 5.72% |
| Revenue Per Employee | 6.34M |
| Profits Per Employee | -20.04M |
| Employee Count | 47 |
| Asset Turnover | 0.06 |
| Inventory Turnover | 0.03 |
Taxes
In the past 12 months, Stella Pharma has paid 2.00 million in taxes.
| Income Tax | 2.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +61.80% in the last 52 weeks. The beta is 0.31, so Stella Pharma's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | +61.80% |
| 50-Day Moving Average | 401.80 |
| 200-Day Moving Average | 418.81 |
| Relative Strength Index (RSI) | 59.43 |
| Average Volume (20 Days) | 758,785 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Stella Pharma had revenue of JPY 298.00 million and -942.00 million in losses. Loss per share was -27.04.
| Revenue | 298.00M |
| Gross Profit | 260.00M |
| Operating Income | -947.00M |
| Pretax Income | -940.00M |
| Net Income | -942.00M |
| EBITDA | -919.00M |
| EBIT | -947.00M |
| Loss Per Share | -27.04 |
Full Income Statement Balance Sheet
The company has 3.81 billion in cash and 859.00 million in debt, with a net cash position of 2.95 billion or 77.56 per share.
| Cash & Cash Equivalents | 3.81B |
| Total Debt | 859.00M |
| Net Cash | 2.95B |
| Net Cash Per Share | 77.56 |
| Equity (Book Value) | 3.28B |
| Book Value Per Share | 90.15 |
| Working Capital | 5.04B |
Full Balance Sheet Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 28.00M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow Statement Margins
| Gross Margin | 87.25% |
| Operating Margin | -317.79% |
| Pretax Margin | -315.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Stella Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -2.39% |
| Shareholder Yield | -2.39% |
| Earnings Yield | -6.27% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Stella Pharma has an Altman Z-Score of 3.79 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.79 |
| Piotroski F-Score | 1 |